Finance

Lists
301263:SHE
Guangdong Taienkang Pharmaceut Co Ltd
CNÂ¥20.17
+0.60%
(+0.12) 1D
Sep 8, 3:04:19 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301263...
Open
CNÂ¥20.05
High
CNÂ¥20.40
Low
CNÂ¥19.88
Mkt. cap
10.01B
Avg. vol.
5.10M
Volume
3.08M
Dividend
0.21%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 1, 2026
52-wk high
CNÂ¥32.50
52-wk low
CNÂ¥17.52
EPS
-CNÂ¥0.01
Shares outstanding
510.60M
No. of employees
1K
Open
CNÂ¥20.05
High
CNÂ¥20.40
Low
CNÂ¥19.88
Mkt. cap
10.01B
Avg. vol.
5.10M
Volume
3.08M
Dividend
0.21%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 1, 2026
52-wk high
CNÂ¥32.50
52-wk low
CNÂ¥17.52
EPS
-CNÂ¥0.01
Shares outstanding
510.60M
No. of employees
1K
About Guangdong Taienkang Pharmaceut Co Ltd
CEO-
Employees1.15K
FoundedJan 22, 1999
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
178.75M
149.07M
189.52M
130.76M
Cost of goods sold
73.61M
84.18M
70.35M
74.87M
Cost of revenue
73.61M
84.18M
70.35M
74.87M
Research and development expenses
20.28M
23.44M
13.59M
16.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
89.57M
61.31M
70.73M
84.21M
Operating expense
109.71M
83.83M
85.13M
106.92M
Total operating expenses
183.32M
168.01M
155.47M
181.78M
Operating income
-4.57M
-18.94M
34.04M
-51.02M
Other non operating income
252.38K
-512.13K
-612.31K
717.14K
EBT including unusual items
-7.07M
-27.84M
30.45M
-47.35M
EBT excluding unusual items
-7.16M
-22.67M
31.60M
-49.54M
Income tax expense
2.87M
-18.62M
5.53M
-18.45M
Effective tax rate
-40.64%
66.87%
18.18%
38.98%
Other operating expenses
-1.09M
685.26K
816.63K
1.71M
Net income
-5.68M
-2.77M
28.58M
-24.86M
Net profit margin
-3.18%
-1.86%
15.08%
-19.01%
Earnings per share
-
-
-
-
Interest and investment income
-
3.23M
1.49M
4.10M
Interest expense
-2.93M
-5.88M
-3.33M
-3.38M
Net interest expenses
-2.93M
-2.65M
-1.83M
720.71K
Depreciation and amortization charges
-
-
-
-
EBITDA
8.53M
-3.00M
49.98M
-34.32M
Gain or loss from assets sale
12.72K
-193.19K
-
78.42K
AI content may include mistakes. Learn more
Google apps